Reference health

Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and Poly(I : C) for enhanced tumoral photodynamic-immunotherapy

https://doi.org/10.1093/nsr/nwab039
CiteStamped reference-health badge
50/50 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 50 checked references that resolve
resolves10.1172/JCI83871
Cancer immunotherapy: harnessing the immune system to battle cancer
resolves10.1126/science.aar4060
Cancer immunotherapy using checkpoint blockade
resolves10.1002/ajh.25418
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
resolves10.1126/scitranslmed.3008068
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
resolves10.1158/1078-0432.CCR-17-0357
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals
resolves10.1186/s40425-019-0625-x
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
resolves10.1016/j.addr.2007.11.005
TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
resolves10.1016/j.jhep.2019.05.031
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis
resolves10.3892/mmr.2019.10853
Expression profile of Toll‑like receptors in human breast cancer
resolves10.1158/1078-0432.CCR-07-0274
Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?
resolves10.1172/JCI81203
STK4 regulates TLR pathways and protects against chronic inflammation–related hepatocellular carcinoma
resolves10.1073/pnas.1714587115
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice
resolves10.1038/s41565-018-0319-4
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
resolves10.1016/j.biomaterials.2018.04.003
Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles
resolves10.1038/nnano.2017.52
A STING-activating nanovaccine for cancer immunotherapy
resolves10.1021/acsnano.0c00602
RNA Origami Nanostructures for Potent and Safe Anticancer Immunotherapy
resolves10.1002/adma.201700548
A Highly Efficient and Photostable Photosensitizer with Near‐Infrared Aggregation‐Induced Emission for Image‐Guided Photodynamic Anticancer Therapy
resolves10.1021/acsnano.9b07972
Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models
resolves10.1002/ange.202009196
Tumor‐Triggered Disassembly of a Multiple‐Agent‐Therapy Probe for Efficient Cellular Internalization
resolves10.1002/adma.201905091
Near‐Infrared Photoactivatable Semiconducting Polymer Nanoblockaders for Metastasis‐Inhibited Combination Cancer Therapy
resolves10.1002/anie.201906288
Organic Semiconducting Pro‐nanostimulants for Near‐Infrared Photoactivatable Cancer Immunotherapy
resolves10.1038/sj.bjc.6603792
CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells
resolves10.1016/j.biomaterials.2017.09.004
AIEgens for biological process monitoring and disease theranostics
resolves10.1021/acs.accounts.8b00060
Aggregation-Induced Emission (AIE) Dots: Emerging Theranostic Nanolights
resolves10.1021/acs.jmedchem.9b02014
Aggregation-Induced Emission Photosensitizers: From Molecular Design to Photodynamic Therapy
resolves10.1002/adfm.202004397
Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged Nanoparticles
resolves10.1039/C9CS00773C
Molecular and nanoengineering approaches towards activatable cancer immunotherapy
resolves10.1002/adma.201603463
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
resolves10.1016/j.addr.2016.02.007
Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems
resolves10.1021/acsnano.8b00553
Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure
resolves10.1080/21691401.2019.1584110
Anti-tumour effects of red blood cell membrane-camouflaged black phosphorous quantum dots combined with chemotherapy and anti-inflammatory therapy
resolves10.1073/pnas.1106634108
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
resolves10.3389/fimmu.2017.00073
From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis
resolves10.1126/sciadv.aaw6870
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
resolves10.1007/s11426-020-9824-2
Red AIE conjugated polyelectrolytes for long-term tracing and image-guided photodynamic therapy of tumors
resolves10.1016/j.bbcan.2019.07.003
Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity
resolves10.1002/adhm.201900791
Tumor Antigen Mediated Conformational Changes of Nanoplatform for Activated Photodynamic Therapy
resolves10.1021/acs.accounts.9b00148
Combining Nanomedicine and Immunotherapy
resolves10.3322/caac.20114
Photodynamic therapy of cancer: An update
resolves10.7150/thno.29746
Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression
resolves10.1016/j.canlet.2019.11.009
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
resolves10.1155/2018/2912671
Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
resolves10.3389/fimmu.2017.01383
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
resolves10.1038/cdd.2017.44
Caspases and their substrates
resolves10.1158/0008-5472.CAN-16-0707
Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels
resolves10.1038/nrc3670
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
resolves10.1615/CritRevImmunol.v32.i2.10
Central and Effector Memory CD4 and CD8 T-Cell Responses to Tumor-Associated Antigens
resolves10.1007/s00005-017-0480-8
Tumor-Associated Macrophages as Target for Antitumor Therapy
resolves10.1080/15384047.2017.1373220
Exploiting poly(I:C) to induce cancer cell apoptosis
resolves10.1038/s41416-018-0328-y
Cytokines in clinical cancer immunotherapy
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1093/nsr/nwab039"><img src="https://citestamp.com/citestamped/10.1093/nsr/nwab039/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1093/nsr/nwab039/badge.svg)](https://citestamp.com/citestamped/10.1093/nsr/nwab039)